Iterum Therapeutics plc (ITRM)

Iterum Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	13.41	6.07	21.09	27.45	14.51	4.8
Short-Term Investments	1.1	17.86	39.71	53.94	2.36	1.14
Cash & Short-Term Investments	14.5	23.93	60.8	81.38	16.87	5.94
Cash Growth	-59.60%	-60.64%	-25.28%	382.46%	183.97%	-93.05%
Other Receivables	0.27	0.23	0.42	1.21	3.74	1.1
Receivables	0.27	0.23	0.42	1.21	3.74	1.1
Prepaid Expenses	0.81	1.43	1.22	0.68	0.8	0.63
Restricted Cash	-	-	-	-	0.06	0.03
Other Current Assets	0.26	-	-	-	-	4.02
Total Current Assets	15.85	25.6	62.44	83.27	21.47	11.72
Property, Plant & Equipment	0.03	0.6	1.84	3.83	5.68	7.72
Other Intangible Assets	-	-	1.72	3.44	-	-
Other Long-Term Assets	0.04	0.06	0.83	0.98	5.64	6.32
Total Assets	15.92	26.26	66.83	91.51	32.79	25.75
Accounts Payable	0.84	5	2.77	0.88	0.82	15.49
Accrued Expenses	3.49	7.76	4.35	1.17	1.83	12.46
Current Portion of Long-Term Debt	13.71	-	-	1.63	6.49	5.8
Current Portion of Leases	0.27	0.37	0.33	0.46	0.57	0.58
Current Income Taxes Payable	-	-	-	0.22	0.1	0.2
Other Current Liabilities	0.4	0.4	1.61	8.59	31.89	2.46
Total Current Liabilities	18.7	13.52	9.06	12.94	41.7	36.99
Long-Term Debt	8.73	18.96	28.47	24.9	35.85	7.63
Long-Term Leases	-	0.19	1.3	3.44	5.17	6.75
Other Long-Term Liabilities	-	-	-	-	0.63	0.63
Total Liabilities	27.43	32.66	38.83	41.28	83.35	51.99
Common Stock	0.23	0.14	0.13	0.12	0.49	0.15
Additional Paid-In Capital	467.75	454.76	451.15	428.61	235.88	208.54
Retained Earnings	-479.49	-461.3	-422.93	-378.49	-286.93	-234.92
Comprehensive Income & Other	0	0	-0.35	-	-	-
Total Common Equity	-11.51	-6.4	28	50.23	-50.56	-26.24
Shareholders' Equity	-11.51	-6.4	28	50.23	-50.56	-26.24
Total Liabilities & Equity	15.92	26.26	66.83	91.51	32.79	25.75
Total Debt	22.7	19.51	30.1	30.43	48.08	20.75
Net Cash (Debt)	-8.2	4.42	30.7	50.96	-31.22	-14.81
Net Cash Growth	-	-85.60%	-39.75%	-	-	-
Net Cash Per Share	-0.50	0.34	2.51	4.68	-19.50	-15.30
Filing Date Shares Outstanding	27.52	16.43	12.71	12.19	11.77	0.99
Total Common Shares Outstanding	22.71	13.5	12.6	12.19	3.3	0.99
Working Capital	-2.85	12.08	53.38	70.33	-20.23	-25.27
Book Value Per Share	-0.51	-0.47	2.22	4.12	-15.34	-26.47
Tangible Book Value	-11.51	-6.4	26.28	46.8	-50.56	-26.24
Tangible Book Value Per Share	-0.51	-0.47	2.09	3.84	-15.34	-26.47
Machinery	0.22	0.22	0.21	0.23	0.34	0.33
Leasehold Improvements	0.15	0.15	0.15	0.15	0.59	0.59

Source: S&P Capital IQ. Standard template. Financial Sources.